Ligand-Binding Affinity of Alternative Conformers of Human Beta(2)-Adrenergic Receptor in the Presence of Intracellular Loop 3 (icl3) and Their Potential Use in Virtual Screening Studies
| gdc.relation.journal | Chemical Biology and Drug Design | en_US |
| dc.contributor.author | Dilcan, Gonca | |
| dc.contributor.author | Doruker, Pemra | |
| dc.contributor.author | Akten, Ebru Demet | |
| dc.contributor.other | Molecular Biology and Genetics | |
| dc.contributor.other | 05. Faculty of Engineering and Natural Sciences | |
| dc.contributor.other | 01. Kadir Has University | |
| dc.date.accessioned | 2019-06-27T08:01:13Z | |
| dc.date.available | 2019-06-27T08:01:13Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | This study investigates the structural distinctiveness of orthosteric ligand-binding sites of several human beta(2) adrenergic receptor (beta(2)-AR) conformations that have been obtained from a set of independent molecular dynamics (MD) simulations in the presence of intracellular loop 3 (ICL3). A docking protocol was established in order to classify each receptor conformation via its binding affinity to selected ligands with known efficacy. This work's main goal was to reveal many subtle features of the ligand-binding site presenting alternative conformations which might be considered as either active- or inactive-like but mostly specific for that ligand. Agonists inverse agonists and antagonists were docked to each MD conformer with distinct binding pockets using different docking tools and scoring functions. Mostly favored receptor conformation persistently observed in all docking/scoring evaluations was classified as active or inactive based on the type of ligand's biological effect. Classified MD conformers were further tested for their ability to discriminate agonists from inverse agonists/antagonists and several conformers were proposed as important targets to be used in virtual screening experiments that were often limited to a single X-ray structure. | en_US] |
| dc.identifier.citationcount | 8 | |
| dc.identifier.doi | 10.1111/cbdd.13478 | en_US |
| dc.identifier.issn | 1747-0277 | en_US |
| dc.identifier.issn | 1747-0285 | en_US |
| dc.identifier.issn | 1747-0277 | |
| dc.identifier.issn | 1747-0285 | |
| dc.identifier.scopus | 2-s2.0-85061485520 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12469/304 | |
| dc.identifier.uri | https://doi.org/10.1111/cbdd.13478 | |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley | en_US |
| dc.relation.ispartof | Chemical Biology & Drug Design | |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | beta(2)-adrenergic receptor | en_US |
| dc.subject | binding affinity | en_US |
| dc.subject | distinct conformer | en_US |
| dc.subject | docking | en_US |
| dc.subject | intracellular loop 3 | en_US |
| dc.subject | scoring function | en_US |
| dc.title | Ligand-Binding Affinity of Alternative Conformers of Human Beta(2)-Adrenergic Receptor in the Presence of Intracellular Loop 3 (icl3) and Their Potential Use in Virtual Screening Studies | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.institutional | Dilcan, Gonca | en_US |
| gdc.author.institutional | Akdoğan, Ebru Demet | |
| gdc.bip.impulseclass | C4 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.description.department | Fakülteler, Mühendislik ve Doğa Bilimleri Fakültesi, Biyoinformatik ve Genetik Bölümü | en_US |
| gdc.description.endpage | 899 | |
| gdc.description.issue | 5 | |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q2 | |
| gdc.description.startpage | 883 | en_US |
| gdc.description.volume | 93 | en_US |
| gdc.identifier.openalex | W2909227109 | |
| gdc.identifier.pmid | 30637937 | en_US |
| gdc.identifier.wos | WOS:000468814500018 | en_US |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 7.0 | |
| gdc.oaire.influence | 2.7929852E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | beta(2)-adrenergic receptor | |
| gdc.oaire.keywords | Binding Sites | |
| gdc.oaire.keywords | Drug Inverse Agonism | |
| gdc.oaire.keywords | Molecular Dynamics Simulation | |
| gdc.oaire.keywords | Crystallography, X-Ray | |
| gdc.oaire.keywords | Ligands | |
| gdc.oaire.keywords | Protein Structure, Tertiary | |
| gdc.oaire.keywords | Molecular Docking Simulation | |
| gdc.oaire.keywords | ROC Curve | |
| gdc.oaire.keywords | Adrenergic beta-2 Receptor Antagonists | |
| gdc.oaire.keywords | Area Under Curve | |
| gdc.oaire.keywords | binding affinity | |
| gdc.oaire.keywords | docking | |
| gdc.oaire.keywords | scoring function | |
| gdc.oaire.keywords | Cluster Analysis | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Receptors, Adrenergic, beta-2 | |
| gdc.oaire.keywords | distinct conformer | |
| gdc.oaire.keywords | intracellular loop 3 | |
| gdc.oaire.keywords | Adrenergic beta-2 Receptor Agonists | |
| gdc.oaire.popularity | 6.1476975E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 0303 health sciences | |
| gdc.oaire.sciencefields | 01 natural sciences | |
| gdc.oaire.sciencefields | 0104 chemical sciences | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.openalex.fwci | 0.576 | |
| gdc.openalex.normalizedpercentile | 0.66 | |
| gdc.opencitations.count | 9 | |
| gdc.plumx.crossrefcites | 7 | |
| gdc.plumx.mendeley | 21 | |
| gdc.plumx.pubmedcites | 3 | |
| gdc.plumx.scopuscites | 10 | |
| gdc.scopus.citedcount | 10 | |
| gdc.wos.citedcount | 10 | |
| relation.isAuthorOfPublication | 558d2b8e-c713-49e0-9350-d354abb5cd69 | |
| relation.isAuthorOfPublication.latestForDiscovery | 558d2b8e-c713-49e0-9350-d354abb5cd69 | |
| relation.isOrgUnitOfPublication | 71ce8622-7449-4a6a-8fad-44d881416546 | |
| relation.isOrgUnitOfPublication | 2457b9b3-3a3f-4c17-8674-7f874f030d96 | |
| relation.isOrgUnitOfPublication | b20623fc-1264-4244-9847-a4729ca7508c | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 71ce8622-7449-4a6a-8fad-44d881416546 |